#mc4rdeficientobesity

Semaglutide matches tirzepatide’s weight loss in MC4R‑deficient patients while also cutting heavy drinking days by 40%. The combined safety and dual‑benefit pro

40% of semaglutide's weight‑loss potential remains untapped because clinicians lack a clear protocol for MC4R‑deficient patients. Discover a step‑by‑step workfl